Background Immune responses on SARS-CoV-2 vaccination in patients receiving anti-CD20 therapies are impaired but vary considerably. We conducted a systematic review and meta-analysis of the literature ...

Objectives To evaluate the efficacy and safety of intravenous ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, active rheumatoid arthritis (RA) patients despite ...

Ahead of the American Society of Clinical Oncology (ASCO) 2025 annual meeting, Sanjay Goel, MD, MS, professor of medicine at Robert Wood Johnson Medical School and medical oncologist at Rutgers ...

Panelists discuss how pulmonary arterial hypertension diagnosis requires comprehensive evaluation including right heart catheterization to confirm hemodynamic criteria, with normal mean PA ...

The 5-year relative survival rate for chronic lymphocytic leukemia (CLL) among adults ages 20 or older is 87%. Treatment can help people manage CLL symptoms and improve their overall outlook.

Based on the US enrollment, Madan concluded that “we can’t know if this therapy may be effective.” Glofitamab, the bispecific CD20-directed CD3 T-cell engager, was granted accelerated approval by the ...

Department of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China ...

Proof-of-concept mouse studies demonstrated that a single intravenous infusion of RNA Gene Writer, delivered in a proprietary LNP, successfully generated functional CAR-T cells in vivo targeting CD19 ...